Social Media Ideas for Kyowa Hakko

Japan's Kirin buys Canadian vitamin maker for $1.3bn in health science push

10 biotechs in Japan to watch in 2026 

While Japan historically lacked foreign investment, the field is becoming more dynamic. Discover ten essential biotech companies in Japan. The post 10 biotechs in Japan to watch in...

<![CDATA[The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan]]>

Lupin Spins Out Two Oncology Programs to Kaveri Therapeutics to Advance its Oncology Strategy

Aims to Raise Capital to Fund Global Clinical Studies for LNP7457 (PRMT5) & LNP8701 (SOS1)

Kirin Holdings Company, Limited 2026 Q2 - Results - Earnings Call Presentation

KANEKA UBIQUINOLâ„¢ WINS NUTRAINGREDIENTS ASIA INGREDIENT OF THE YEAR: HEALTHSPAN AWARD 2026

Award Shines Spotlight on Ubiquinol's Role in Mitochondrial Health and Mitoceutical Innovation in the Global Healthspan Movement

AGC and Neusignal Therapeutics Collaborate on the Development of Alzheimer's Disease Drug Candidate “NTX-083”

AGC Inc. (Headquarters: Tokyo; President: Yoshinori Hirai; hereinafter “AGC”) highlights its end-to-end support capabilities as a small-molecule pharmaceutical CDMO as demonstrated...

Commercialization of Ultra-High-Purity Colloidal Silica for State-of-the-Art Semiconductors —New production facilities t...

Mitsubishi Chemical Corporation (Head Office: Chiyoda-ku, Tokyo; President: Manabu Chikumoto; hereinafter “the Company”) hereby announces that it has decided to commercialize ultra...

Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bis...

HONG KONG, Aug. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2026 interim results. During the reporting period, the Company achieved reco...

Shionogi CEO says firm is pursuing acquisitions and mulling expanded U.S. production

The pharmaceutical manufacturer wants to accelerate its overseas growth while broadening its portfolio beyond its traditional strength in infectious disease medications.

Astellas Becomes Host City Partner for One Young World 2027 Tokyo Summit

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that it has become the first Host City Partner for the One Young World 2027 Tokyo Su...

<![CDATA[Licensing Roundup: Biohaven & SK Biopharmaceuticals Enter Deal for BHV-7000, Haisco License’s Sentivera...

Kedrion Biopharma extends U.S. agreement with Grifols

Kedrion Biopharma, a Fort Lee-based global biopharmaceutical company specializing in therapies for rare and serious diseases, announced an extension of its relationship with Grifol...

PLT Health Solutions Heads to Vitafoods Asia 2026 as a First-Time Exhibitor, Debuting Next-Gen Kinexa in Asia

PLT Health Solutions is exhibiting at Vitafoods Asia for the first time, setting up at Booth H6-K58 this September 2-4 in Bangkok, Thailand with a portfolio of more than 30 clinica...

Japan looks to turn Osaka and Kobe into biotech hubs

Sunshine Guojian Releases 2026 Interim Report:

Innovation-driven, Steady Advancement

Eldex Corporation Strengthens Long-Term Scientific Engagement Through Continued Partnership with Bioz

<![CDATA[Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement ]]>

Merck KGaA (MKKGY) Q2 2026 Earnings Call Transcript